Skip to content

Efficacy Evaluation of Avance QQ Collagen for Skin Beautification

Efficacy Evaluation of Avance QQ Collagen for Skin Beautification

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06771388
Enrollment
75
Registered
2025-01-13
Start date
2024-11-01
Completion date
2025-02-28
Last updated
2025-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liposomal Encapsulation, Skin Condition

Keywords

Avance QQ Collagen, Double Nutri

Brief summary

To assess Avance QQ Collagen product on skin condition improvement

Interventions

DIETARY_SUPPLEMENTLiposomal collagen drink

consume 50 g liquid drink daily for 8 consecutive weeks

DIETARY_SUPPLEMENTNon-liposomal collagen drink

consume 50 g liquid drink daily for 8 consecutive weeks

DIETARY_SUPPLEMENTPlacebo drink

consume 50 g liquid drink daily for 8 consecutive weeks

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female adults, age above 18 years old; * The grade of crow's feet above 2 (Han et al. Sci Rep 13, 18903 (2023)); * Commitment not to use products having activity comparable with that of the product to be tested during the study period; * Free of any dermatological or systemic disorder that would interfere with results.

Exclusion criteria

* Subject with obvious skin surface damage; * Subject who had oral or topical medication which may affect skin condition within 1 month; * Subject who is a vegetarian or likely to be acutely allergic to the listed ingredients in the product; * Female who is pregnant, nursing or planning to become pregnant during the course of the study; * Received facial laser therapy, chemical peeling in the past 2 months.

Design outcomes

Primary

MeasureTime frameDescription
The change of skin elasticityChange from Baseline skin elasticity at 8 weeksCutometer® MPA580 was utilized to measure skin elasticity. Units: arbitrary units
The change of skin collagen densityChange from Baseline skin collagen density at 8 weeksDermaLab® Series SkinLab Combo was utilized to measure skin collagen density. Units: arbitrary units
The change of skin wrinklesChange from Baseline skin wrinkles at 8 weeksVISIA Complexion Analysis was utilized to measure skin wrinkles. Units: the amount of detectable wrinkles

Secondary

MeasureTime frameDescription
The change of skin lightnessChange from Baseline skin lightness at 8 weeksChroma Meter MM500 was utilized to measure face skin lightness. Units: L\* index
The change of skin toneChange from Baseline skin tone at 8 weeksChroma Meter MM500 was utilized to measure face skin color. Units: Individual Typology Angle (ITA°)
The change of wrinkles around the eyesChange from Baseline wrinkles around the eyes at 8 weeksVISIA Complexion Analysis was utilized to measure wrinkles around the eyes. Units: the amount of detectable wrinkles
The change of skin hydrationChange from Baseline skin hydration at 8 weeksCorneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation. Units: arbitrary Corneometer® units 0-120.

Other

MeasureTime frameDescription
The change of self-assessment skin conditionChange from Baseline skin condition at 8 weeksA self-assessment questionnaire was collected and evaluate skin condition.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026